Keller et al.1993
Keller ET, MacEwen EG, Rosenthal RC, et al: Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma. J Vet Intern Med 7:289, 1993. The Madison-Wisconsin protocol results in 30% long-term survivals of more than 2 years.
